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1 Zusammenfassung 
Für die Conservation Medicine bei Löwen sind Kenntnisse über das Vorkommen 
von Infektionserregern von zunehmender Bedeutung. Da nur wenige Daten über 
Simbabwe zur Verfügung stehen, war Ziel es dieser Studie, das Vorkommen und die 
Zusammenhänge von Antikörpern gegen verschiedene Infektionserreger in 
Serumproben von Löwen aus Simbabwe nachzuweisen und die Resultate mit 
anderen Regionen Afrikas (Tansania, Kenia, Südafrika, Namibia) zu vergleichen. 
Die Serumproben (n=72) wurden von 1993 bis 2003 von wilden und in 
Gefangenschaft lebenden Löwen entnommen. Untersucht werden Antikörper gegen 
das Feline Herpesvirus (FHV), Calicivirus (FCV), Parvovirus (FPV), Coronavirus 
(FCoV), Immundeffizienzvirus (FIV), Leukämievirus (FeLV), Canines Staupevirus 
(CDV), Toxoplasma gondii, Ehrlichia canis und Anaplasma phagozytophilum. 
Bei den wilden Löwen (n=43) kommen Antikörper gegen FHV und T.gondii sehr 
häufig vor (FHV, 81%; T.gondii, 86%). Basierend auf der Kreuzreaktivität von FIV in 
Westernblots wird der Schluss gezogen, dass das Löwenlentivirus bei wilden Löwen 
in Zimbabwe endemisch vorkommt, da 52% der Proben positive Resultate geben. 
Ein Kontakt mit FPV kann in 23% der Proben festgestellt werden. Tiefe Prävalenzen 
finden wir bei FCoV (7%), A.phagazytophilum (14%) und bei CDV (7%). Keine 
Evidenz gibt es für das Vorkommen von E. canis, FCV und FeLV. 
Die Prävalenzen variieren zwischen den verschiedenen Regionen des südlichen und 
östlichen Afrikas, daraus folgt, dass das Umplatzieren von Tieren sehr überlegt 
vorgenommen werden muss. 
 
2 Abstract 
Information about the exposure of lions (Panthera leo) to infectious agents is of 
increasing importance for conservation medicine. Only limited data are available for 
Zimbabwe. Thus, the aims of this study were to investigate the prevalences and 
interrelationships of antibodies to several infectious agents in serum samples from 
lions in Zimbabwe and to compare these results to those reported from other regions 
in Africa (Tanzania, Kenya, South Africa, Namibia). Serum samples (n = 72) collected 
between 1990 and 2003 from free-ranging and captive lions were analyzed regarding 
to antibodies to feline herpesvirus (FHV),  calicivirus (FCV), parvovirus (FPV), 
coronavirus (FCoV), immunodeficiency virus (FIV), leukaemia virus (FeLV), canine 
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distemper virus (CDV), Toxoplasma gondii, Ehrlichia canis, and Anaplasma 
phagocytophilum. Among the free-ranging lions (n = 43) antibodies to FHV and to 
T. gondii were highly prevalent (FHV, 81%; T. gondii, 86%). Based on the 
crossreactivity with FIV in Western blots, it was concluded that a lion lentivirus is 
endemic in free-ranging lions in Zimbabwe as 52% of the samples were considered 
positive. Exposure to FPV could be detected in 23% of the samples. We found low 
prevalences of antibodies to FCoV (7%), A. phagocytophilum (14%), and CDV (7%) 
and no evidence for exposure to E. canis, FCV and FeLV. Prevalences vary in 
different regions of southern and eastern Africa, thus any translocation of animals 
must be considered carefully. 
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3 Introduction 
During recent years there has been an increasing interest in infectious diseases in 
free-ranging lions (Panthera leo). Besides zoological and ethological aspects, 
profound knowledge of the infectious status is important. The loss of habitat might be 
the most important factor for decreasing population sizes. However, for conservation 
purposes, the understanding of infectious agents also plays an important role, 
especially while planning translocations of seropositive animals to seronegative lion 
populations. Transmission of several infectious agents may be more efficient in lions 
than in other species of wild felids because lions are social animals living in prides. 
This fact may raise the susceptibility of lions to epidemic diseases like the canine 
distemper virus CDV outbreak that struck the Serengeti lions in late 1993 - early 1994 
(23). The pathogenetic role of some of the infectious agents for lions is still unclear. 
In contrast, there is profound knowledge about the agent’s different transmission 
modes, symptoms and durations of infections in domestic cats (13) as these 
diseases are of veterinary interest. In the domestic cat, feline calicivirus (FCV) 
causes inflammatory lesions in the oral cavity (gingivitis, vesicles on the tongue) 
affection of the joints and rarely a hemorrhagic-like fever (20). Feline parvovirus 
(FPV) is responsible for diarrhea and bone marrow depression often leading to 
leucopenia especially in young cats. Feline herpes virus (FHV) is responsible for 
rhinitis and conjunctivitis; infected cats remain latently infected for prolonged time. 
Feline coronavirus (FCoV) usually does not cause disease but occasionally mutates 
and induces fatal infectious peritonitis. Feline immunodeficiency virus (FIV) leads to 
loss of CD4+ lymphocytes and to immunodeficiency eventually resulting in death from 
opportunistic infections. Feline leukemia virus (FeLV) induces viremia in a portion of 
infected cats resulting in immunosuppression, anemia or lymphoma/leukemia. In the 
present study we investigated the prevalence of antibodies to the above viral feline 
infections. In addition, antibodies to canine distemper (CDV), to Ehrlichia canis 
(E. canis), to Anaplasma phagocytophilum (A. phagocytophilum) and to Toxoplasma 
gondii (T. gondii). CDV is usually important for dogs where it causes 
immunosuppression, affections of the respiratory tract and the central nervous 
system. Occasionally, CDV crosses species and induces severe epidemic outbreaks 
with high mortality in large felids (23). E. canis and A. phagocytophilum are rickettsial 
infections transmitted by tick vectors infecting blood leukocytes. E. canis can cause 
severe clinical signs in dogs while A. phagocytophilum affects several species and 
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usually causes transient fever and depression. Toxoplasma gondii is a protozoan 
parasite infecting a wide range of intermediate hosts resulting in the formation of 
extraintestinal tissue cysts of long persistence. In definitive hosts, the cat and other 
felid species, parasite development includes an intestinal phase with subsequent 
excretion of parasite oocysts and the formation of tissue cysts as in intermediate 
hosts. The detection of anti-Toxoplasma antibodies identifies animals carrying tissue 
cysts and was performed in this study as T. gondii infection was reported to be of 
clinical importance in lions (18) and to be widespread in southern Africa (4). 
 
In East Africa, FCV, FPV, FHV, FCoV, and FIV infections were reported to be all 
highly prevalent (10). In contrast, in the Kruger National Park, FCV and FCoV 
infections were not observed (27) and interestingly, in Etosha with exception of FHV, 
the other viral infections were largely absent (29). 
As there is only limited information available on infectious diseases in lions in 
Zimbabwe in southern Africa (Fig. 1), the present study was undertaken to determine 
the seroprevalences of the above mentioned infections and to compare the results 
with those of other countries in Africa. 
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4 Material and Methods 
4.1 Animals and samples 
Between 1990 and 2003, 72 serum samples were collected from 43 free-ranging and 
from 29 captive lions (Panthera leo) by a team of field researchers under the 
supervision of one of us (C.F.). The numbers of lions sampled per year were 4 for 
1990, 4, 7, 8, 3, 6, 5, 24, 10 and 1 for the years of 1995 to 2003, respectively. 
Information on sex and age was available from 51 and 50 animals, respectively. The 
free-ranging lions inhabited areas next to Lake Kariba, Mola (n=1), Bumi Hills (n=11), 
Fothergill Is. (n=3), Tashinga (n=2), also Chiredzi, Malilangwe (n=11), Zambezi 
Valley, Mana Pools (n=11), and Hwange National Park, Main Camp (n=2), 
Sinamatella (n=1) (Fig. 1). No information was available about the origin of one free-
ranging lion. Fothergill Island and Tashinga are in the Matusadona National Park, on 
the shores of Lake Kariba, and the lions sampled there are part of a contiguous 
population, as are the lions of Mola and Bumi Hills. 
The sera were stored at -20°C until examination. Samples were sent for analysis by 
air courier to our laboratory. Shipment of samples was in accordance with a CITES 
import permit. 
All sera were examined for the presence of antibodies to FHV, FCV, FPV, FCoV, 
FeLV, FIV, CDV, E. canis, A. phagocytophilum and T. gondii. FIV-Western blot 
testing was performed with all sera with the exception of 1 due to its limited quantity. 
Results were analyzed with respect to habitat, sex and age of the sampled animals 
as well as the year of blood collection. 
4.2 Serological assays 
4.2.1 Detection of antibodies to FHV, FCV, FPV 
Antibodies to FHV, FCV and FPV were detected by immunofluorescence assay 
(IFA), as described previously (10). The IFA tests were carried out using slides 
masked with Teflon coating leaving open 10 dots where the antigen-containing cells 
were attached. 
Preparation of the virus-infected cells: briefly, CRFK cell monolayers were grown in 
75 cm2 cell culture flasks in RPMI 1640 medium (Sigma, Buchs SG, Switzerland) with 
10% fetal calf serum (Bio concept, Allschwil, Switzerland), 1% L glutamine 200 mM 
(Invitrogen, Basel, Switzerland) and 1% Antibiotic/Antimycotic Solution (PEN G, SPT, 
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AMB; Invitrogen) at 37°C, 5% CO2. When the monolayers showed 90% confluence 
they were infected by the different viruses and harvested when the cytopathic effect 
(the cells rounded up and detached from the bottom of the flask) reached 60% of the 
cells. The detached cells were removed with the medium and washed twice with 
Hanks balanced salt solution (HBSS; Invitrogen, Basel, Switzerland). At the same 
time, mock-infected cells were grown and handled under identical conditions and 
mixed with the infected cells at a ratio of 80% infected to 20% non-infected. 
For infection, the following viruses were used: FPV (FPL/01, Intervet, UK), FCV (F9 
strain, Intervet, UK), and FHV (Zurich 5-04, a Swiss isolate obtained from a cat 
suffering from a herpes keratitis). All viruses were tested for the absence of 
contaminations by other viruses and agents by PCR and RT-PCR specific for FHV, 
FCV, FPV, FCoV, FIV, FeLV, CDV, A. phagocytophilum and E. canis. 
Preparation of the IFA slides: 7 µl of a suspension containing 1.5 X 106 cells per ml 
were placed on each well. The slides were air-dried, fixed in acetone for 10 min at -
20°C, and stored at -20°C. 
IFA testing: the sera were screened at a dilution of 1:20 in phosphate buffered saline 
(PBS; 2 mM NaH2PO4, 8 mM NaHPO4, 0.15 M NaCl, pH 7.2). Incubation was carried 
out at 37°C for 60 min; after a washing step and air drying, FITC conjugate (rabbit 
anti cat IgG, H+L chain, Nordic Immunology, Tilburg, The Netherlands) diluted 1:40 in 
PBS was added for 60 min at 37°C. After a final wash (PBS), the slides were 
examined under a fluorescent microscope. The result was considered positive when 
specific fluorescence was detected in infected cells with a serum dilution of ≥ 1:20. 
Positive serum samples were titrated until end point on two-fold serial dilutions under 
conditions described above. 
4.2.2 Detection of antibodies to FCoV 
Antibodies to FCoV were detected by IFA as described previously (10). The sera 
were screened at a dilution of 1:20 in PBS. Any positive serum sample was titrated to 
dilutions of 1:25, 1:100, 1:400 and 1:1600. 
4.2.3 Detection of antibodies to FeLV 
Antibodies to FeLV p45, the unglycosylated form of gp70, were measured by 
enzyme-linked immunosorbent assay (ELISA) as described previously (10). Samples 
yielding > 25% of the positive control, run with each assay, were considered positive. 
Additionally, the questionable sera (> 15% and ≤ 25% of the positive control) were 
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examined for the presence of antibodies to FeLV by Western blot (14). Samples 
containing antibodies to gp70, p58, p27, p15 and p12 were judged positive (15). 
4.2.4 Detection of antibodies to FIV 
To detect antibodies to the lion lentivirus, domestic cat FIV Z2 (Zurich 2 strain) was 
used as antigen. Antibodies were detected by the Western blot technique as 
described previously (14). The presence of both the p24 band and p15 band and the 
presence of p24 band alone were interpreted as a positive result. 
The sera were also tested by ELISA using recombinant FIV Z2 transmembrane 
glycoprotein (designated TM ELISA) as described elsewhere (3). Samples that 
reached an OD value > 50% of the positive control were considered positive. 
4.2.5 Detection of antibodies to CDV 
Antibodies to CDV were detected by IFA and immunohistochemistry using antigens 
produced as described (5). Briefly, for IFA the following conditions were used: 
Confluent VERO cell monolayers grown under the same conditions as described for 
CRFK were infected with CDV (Onderstepoort strain). The cells were removed from 
the bottom of the 75 cm2 cell culture flask using 1 ml of Trypsin-EDTA (Invitrogen; 
2.5 g/L of Trypsin and 0.38 g/L of EDTA in HBSS) when 30% of the cells were 
infected. These cells were used for IFA under conditions identical to those described 
above for FPV, FCV, FHV. Additionally, in every second well 100% non-infected cells 
were placed in order to have an external negative control. All sera were screened at 
a dilution of 1:80. Positive serum samples were titrated up to 1:320. Positive and 
questionable samples were confirmed using immunohistochemistry. 
Immunohistochemistry: VERO cells were grown on glass cover slips and infected 
with CDV (Onderstepoort strain and A75/17-CDV, respectively). When cytopathic 
effect reached 30%, the cells were washed 3 times with Tris-buffered saline (TBS; 
Sigma) and blocked with normal goat serum (diluted 1:20 in TBS) for 20 min. The 
serum dilutions (1:200) in TBS were added without washing. After incubating for 2 h, 
the cover slips were washed and a peroxidase-conjugated goat anti-cat IgG 
preparation (Jackson ImmunoResearch Laboratories, West Baltimore Pike, 
Pennsylvania, USA) at a dilution of 1:1,000 was added and incubated for 1 h at 37°C. 
After washing thoroughly with TBS the substrate (1.85 mM 3,3’ Diaminobenzidine 
Tetrahydrochloride dissolved in TBS, 0.24‰ H2O2) was added. The enzymatic 
reaction was stopped after 10 min at 37°C. 
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4.2.6 Detection of antibodies to Toxoplasma gondii 
96-well microtiter plates (Nunc Maxisorp, Nunc, Denmark) were coated with 
Toxoplasma antigen (Virion Ltd, Rueschlikon, Switzerland) at a concentration of 5.5 
µg/ml carbonate/bicarbonate buffer (0,1 M, pH 9.6) containing 0.02% NaN3, overnight 
at 4°C. 
Plates were washed three times with 0.9% NaCl/0.3% v/v Tween 20 and saturated 
for 30 min at 37°C with PBS (pH 7.2) containing 0.02% NaN3, 0.05% bovine 
hemoglobin and 0.3% v/v Tween 20 (PBS-T). Sera were diluted 1:200 in PBS-T and 
100 µl per well were used. After incubation for 1 h at 37°C plates were washed four 
times and 100 µl per well detection antibodies conjugated to alkaline phosphatase 
(goat anti feline IgG, Southern, 1:4,000 in PBS-T) were added. After 1 h at 37°C 
plates were washed four times and 100 µl of a 1 mg per ml solution of p-nitrophenyl 
phosphate (Sigma) in 0.05 M carbonate/bicarbonate buffer containing 1mM MgCl2 
(pH 9.8) were added to each well. After 15 min the reactions were stopped by 
addition of 50 µl of 3 M NaOH. Absorbance was measured at 405 nm. The procedure 
had been optimized with regard to antigen concentration and conjugate dilution in 
pre-experiments (data not shown). Samples reaching an OD value > 50% of the 
control serum were judged positive. The threshold was based on the mean OD value 
plus 3 standard deviations of 20 Toxoplasma-free domestic cats. 
4.2.7 Detection of antibodies to Anaplasma phagocytophilum and 
Ehrlichia canis 
Exposure to A. phagocytophilum and E. canis was tested by IFA at a 1:80 starting 
dilution of all sera. E. canis slides (VMRD, Inc. Pullman, Washington, USA) were 
used for the detection of antibodies to E. canis, and E. equi slides (VMRD) for the 
detection of antibodies to A. phagocytophilum, respectively. Positive sera were 
titrated and examined until end point on two-fold serial dilutions. Samples reaching a 
titer ≥ 1:80 were considered positive. 
4.3 Quality control of antigen preparation, total nucleic acid extraction and 
PCR 
All antigens used for the immunofluorescence assays (IFA) were tested by PCR or 
RT-PCR for absence of possibly contaminating antigens. To this end, aliquots of the 
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cell cultures or scrapings from the slides were tested for presence of FCV, FHV-1, 
FPV, FCoV, CDV, FIV, FeLV, A. phagocytophilum and E. canis. 
For the extraction of nucleic acids from the aliquots, the MagNA Pure LC instrument 
(Roche Diagnostics AG, Rotkreuz, Switzerland) using the Total Nucleic Acid Isolation 
Kit (Roche Diagnostics AG) was used. Briefly, 140 µl of the aliquots or the scrapings 
from the slides were incubated at 40°C for 10 min in 300 µl lysis buffer. The purified 
nucleic acids were eluted in a final volume of 100 µl. 
The extracted total nucleic acid samples were analyzed by one-tube real-time PCR 
using an automated fluorometer (TaqMan, ABI 7700, Applied Biosystems, Rotkreuz, 
Switzerland) for the presence of the agents of interest using the following primers or 
conditions: FCV: primers and probe sequences were slightly derived from those 
published (9) and kindly provided by C. Helps: forward 5’-
GTTGGATGAACTACCCGCCAATC-3’, reverse 5’-
CATATGCGGCTCTGATGGCTTGAAACTG-3’, probe 5’-
TCGGTGTTTGATTTGGCCTG-3’. CDV was tested as described (7). Conditions were 
as published for FHV (30), FPV (17), FCoV (8, 17), FIV (1), FeLV (11), 
A. phagocytophilum (21) and E. canis (21). 
4.4 Statistical methods 
Frequencies were compared by the Pearson Chi square test and the actus 
randomization test (6) followed by Bonferroni correction (22). Fisher’s exact test was 
used when a table had a cell with an expected frequency of less than 5 (SPSS, 
version 11.5). Differences were considered significant at p < 0.05. 
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5 Results 
All results were analyzed with respect to habitat, sex and age of lions and year of 
blood collection if the respective information was available. Whenever a correlation 
between the results and the above mentioned parameters was found, it is stated; 
otherwise no information is given. 
The overall prevalence of antibodies to selected feline and canine infectious agents 
in captive and free-ranging lions is compiled in Table 1. The seroprevalences 
according to geographical locations in free-ranging lions are shown in Table 2. 
5.1 Prevalence of antibodies to FHV 
Titers ranged from 20 to 320. A significant difference was found to be related to the 
origin of the samples (pchi < 0.0001): 35 of 43 (81%) sera from free-ranging lions 
tested positive. In contrast, only 7 of 29 captive lions produced antibodies with 
reactivity to FHV (p < 0.01). 
A positive FHV antibody status was significantly associated with antibodies to 
T. gondii (pchi < 0.001) (Table 5). 
5.2 Prevalence of antibodies to FCV 
One captive animal had a low titer of 40. This serum also tested positive for 
antibodies to FHV. 
5.3 Prevalence of antibodies to FPV 
The titers ranged from 20 to > 10,240. Low titers (< 160) were detected in 8 lions, 
whereas high titers were found in 18 animals. A significant association was found 
with sex of the lions (pchi = 0.023): 9 out of 17 samples of male lions test positive 
(53%). In contrast, only 7 out of 33 samples of lionesses were positive (21%). 
5.4 Prevalence of antibodies to FCoV 
Among the 72 lions, 5 were FCoV antibody positive with titers of 25 (2 free-ranging 
and 3 captive lions) while 1 free-ranging animal had a titer of 100. 
5.5 Prevalence of antibodies to FeLV 
All lions tested negative for the presence of antibodies to FeLV. Out of the 72 serum 
samples, 7 samples reached levels between 15 to 22% of the positive control when 
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tested by ELISA. When tested by Western blot, none yielded the typical pattern of 
FeLV antibodies; all sera were therefore judged negative. 
5.6 Prevalence of antibodies to FIV 
The results of the serum samples tested for antibodies to FIV are summarized in 
Table 3.  
A total of 53% of the free-ranging and 21% of the captive lions were FIV positive. 
FIV positivity was significantly associated with free-ranging (p < 0.05) and the age of 
the lions (pchi = 0.006): 16 of 34 adult animals showed antibodies to FIV (47%). In 
contrast, only 1 out of 15 juveniles (< 4y) tested positive (7%). From 32 animals, the 
age was unknown. A significantly different prevalence was found when the data were 
analyzed according to the origin of the lions sampled (pchi = 0.007): 22 of 42 free-
ranging lions tested positive (52%) whereas only 6 of 29 captive lions had a positive 
test result (21%). Regardless of the origin, the virus was endemic in every region 
sampled with the exception of two groups of captive lions and one group of 3 free-
ranging lions inhabiting Hwange National Park.  
There were some significant associations between antibodies to FIV and antibodies 
to FHV and T. gondii (Table 4). Antibodies to FHV and to T. gondii were significantly 
associated with FIV seropositivity (pchi = 0.029). 
None of the samples tested in TM ELISA was considered positive (> 50% of positive 
control). 
5.7 Prevalence of antibodies to CDV 
Three out of the five CDV positive sera were confirmed to be positive by 
immunohistochemistry (4%). The 3 lions were free-ranging and were sampled in 
Matusadona National Park (pchi < 0.001) (Table 2). 
5.8 Prevalence of antibodies to Toxoplasma gondii 
A significant association was found with the origin of the serum samples 
(pchi < 0.0001): the majority of the free-ranging lions (86%) showed antibodies with 
reactivity to T. gondii. In contrast, in captive animals the prevalence of antibodies to 
T. gondii was 31%. There was a significant positive correlation between antibodies to 
T. gondii and antibodies to FHV (pchi < 0.001). A positive T. gondii status was 
significantly associated with absence of antibodies to both FPV (pchi = 0.005) (Table 
5). 
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5.9 Prevalence of antibodies to Anaplasma phagocytophilum 
Among the 81 lions, 6 sera showed specific fluorescence to A. phagocytophilum 
(7%). The titers ranged from 80 to 640. All positive animals were free-ranging. 
5.10 Prevalence of antibodies to Ehrlichia canis 
Antibodies to E. canis were detected in none of the 72 serum samples tested. 
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6 Discussion 
In the present study serum samples collected from free-ranging and captive lions 
from Zimbabwe were analyzed for the presence of antibodies to various infectious 
agents. The study was undertaken as only limited information was available to date 
on the infectious disease status of Zimbabwean lions. In past studies major 
differences had been observed in the prevalence of numerous diseases in lions 
originating from East Africa, West Africa and South Africa (1, 10, 27-29) (Table 6). 
An ideal basis for any seroprevalence study would be a serum collection carried out 
within a defined, short period of time in order to establish sound information on a 
given time point. The present study is based on serum samples collected 
opportunistically over a time period of twelve years from lions immobilized for various 
reasons such as translocations and radio-collaring. Therefore the present study was 
not done under ideal conditions but allows an assessment of the infections studied. 
6.1 Feline herpes virus 
The overall prevalence of FHV antibodies of 81% in free-ranging lions is in good 
agreement with the situation in the Serengeti National Park, the Ngorongoro Crater, 
the Lake Manyara region, the Kruger National Park, and the Etosha National Park; in 
all these areas the prevalence of FHV was generally high (Table 6). The observation 
that FHV prevalence is higher in free-ranging than in captive lions may be explained 
by the fact that captive animals are generally kept isolated, thus there is reduced 
contact. 
6.2 Feline calici virus 
No FCV antibodies were found in lions with exception of one captive animal., 
Therefore, FCV is of no importance in free-ranging lions in Zimbabwe. This is in 
agreement with the situation found in the Ngorongoro Crater, Lake Manyara region, 
the Kruger Park, and the Etosha National Park, where FCV was undetectable (10, 
27, 29), but in contrast to that in the Serengeti National Park, where the FCV 
prevalence was found to be 67% (10) (Table 6). No explanation can be offered for 
the high prevalence of antibodies to FCV in the Serengeti and the low prevalence in 
Zimbabwe. Certainly, it cannot be explained by different assays as in both studies the 
same antigen was used. 
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6.3 Feline parvo virus 
FPV antibodies were readily detected in free-ranging lions, with a prevalence of 23%. 
Thus, FPV infection seems to be of considerable importance. This is in contrast to 
the findings in Etosha where the prevalence was found to be zero (29), but is in 
agreement with the situation in East and South Africa with prevalences between 27 
and 84% (10, 27, 29) (Table 6). The observation that FPV antibodies were 
significantly associated with the male sex might be explained by the fact that young 
adult male lions usually have to leave their pride and will wander around to a greater 
extent than their female family members thus increasing the chance of exposure to 
the virus.  
6.4 Feline corona virus 
The prevalence of 7% found in 43 free-ranging Zimbabwean lions was not surprising. 
It was in the same range as in the Etosha National Park, though the prevalence in 
the Kruger National Park was 0% (27). However, this is significantly lower than in the 
lion populations in East Africa. In the earlier paper (10), we had speculated that the 
difference in the FCoV prevalence in East and South Africa might be due to assay 
conditions, which were not known for reports emanating in South and West Africa 
(27, 29). The test used for the present study was identical to the one used previously 
in East Africa (10) so that a difference can hardly be explained by varying assay 
conditions. In view of the fact that the same assay found a high prevalence of FCoV 
antibodies in East Africa but a low in Zimbabwe, it appears likely that indeed the 
prevalence of FCoV antibodies in lions in West and South Africa is less than in 
Tanzania and in Kenya (Table 6). This does not rule out the possibility that different 
subtypes of FCoV may be present in these different locations. 
6.5 Feline leukaemia virus 
None of the lions in the present study tested positive for FeLV antibody, which is 
identical to all other lion populations studied so far. We conclude that FeLV infection 
also in Zimbabwean lions does not play a major role. 
6.6 Feline immunodeficiency virus 
In the present study 52% of the free-ranging animals were positive by WB using 
domestic cat FIV. This included samples which produced only a single p24 band in 
Western blots and samples that recognized several major bands. This prevalence is 
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significantly lower than that found in East Africa and in the Kruger National Park, 
where it was higher than 90% (Table 6). In the present study, we considered as 
positive also those samples that recognized only the p24 band and with this may 
have overestimated the true prevalence. In man, it has been shown that antibodies 
reacting with HIV p24 can be induced not only by HIV but also by influenza infection 
based on a short identical amino acid sequence present on HIV p24 and influenza 
virus. In the diagnosis of HIV infection, it is a well known phenomenon that 
occasionally antibodies to p24 are detected in individuals that are not infected with 
HIV. These reactions can be explained by the presence of antibodies induced by 
peptides of unknown infectious agents which are similar or identical to peptides of 
HIV p24 (2, 25). A similar cross reactivity could also exist in lions. From this it must 
be concluded that the true prevalence of lentivirus infection in Zimbabwean lions is 
indeed much lower than in East or South Africa, or that a virus is present in this 
population which is more distantly related from the domestic cat FIV than the 
lentivirus present in East Africa or in the Kruger National Park.  
As in previous studies, the Zimbabwean lions showed a significant association of FIV 
infection with age. This most likely reflects the fact that exposure to FIV increases 
with age (19). Interestingly, lions kept in captivity showed a significantly lower 
prevalence of FIV than those in the wild. It appears that the lower prevalence is not 
associated with younger age as there was no significant difference in the age of the 
captive versus free-ranging lions. An explanation could be that lions in captivity 
generally would fight less than in the wild because they are living in smaller groups 
and have no territory to defend against intruders, or that fact that the populations are 
closed. The strong association between FIV, FHV and T. gondii infection is most 
likely due to the differences in the prevalences of both infections in captive and free-
ranging lions and therefore do not represent causal associations. 
6.7 Canine distemper virus 
The prevalence of antibodies to CDV was low, which is similar to the situation in the 
Serengeti lion population shortly before a severe outbreak of CDV infection in 1994 
(19, 23). While in East Africa it was clearly shown that the prevalence of antibodies to 
CDV varied over time, the prevalence of antibodies to CDV in Zimbabwean lions 
seems to have remained low over an extended period of time (12 years of sampling). 
Positive IFA results were confirmed by the highly specific immunohistochemistry (5). 
As only three out of five IFA positive samples were clearly confirmed by 
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immunohistochemistry, the true prevalence of antibodies to CDV must indeed be very 
low in the Zimbabwean lions. Generally, the areas where free-ranging Zimbabwean 
lions roam are less populated by humans and dogs than in East Africa, which may 
account for the difference in CDV seropositivity. Alternatively, because Rinderpest, 
which has close cross-reactivity to CDV (26), has been absent from Zimbabwe since 
1900, and vaccination has never been introduced in the country, the possibility of 
Rinderpest virus inducing seroconversion detectable by CDV antigen in lions in 
Zimbabwe does not exist. The 3 positive lions originated from the Matusadona 
National Park. This observation is surprising because more dog contacts would have 
been expected in the Mola/Bumi area. 
6.8 Toxoplasma gondii 
Antibodies to T. gondii were highly prevalent. This observation is in agreement with 
previous studies from South Africa (4). The significant difference between the test 
results of free-ranging (86% positive) and captive lions (32% positive) could be 
explained by differences in the diet. Captive lions are usually fed carcass material 
from domestic cattle. 
6.9 Anaplasma phagocytophilum 
Although interesting, the 14% prevalence of antibodies to A. phagocytophilum in free-
ranging lions is not a surprise, because many genera of ticks are present in 
Zimbabwe and will feed on lions. A. phagocytophilum is known to affect many 
species worldwide (7, 12, 16, 24). Antibodies to A. phagocytophilum have not been 
previously reported, so the high titers recorded in this study cannot be said to be 
unusual. The pathogenicity of A. phagocytophilum for lions is unknown. 
6.10 Ehrlichia canis 
No lion tested positive for E. canis. This could mean that either E. canis does not 
infect lions or if it does it is highly pathogenic and leads to rapid disease progression 
and death thereby eliminating all animals that might have been infected. Interestingly, 
we have recently identified a wild puma in Brazil with a very high titer to E. canis (7) . 
This suggests that also lions may be susceptible for E. canis infection. E. canis 
infection is commonly diagnosed in dogs in Zimbabwe. 
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This study has shown that lions in Zimbabwe may be infected with a large variety of 
infectious agents which vary in prevalence in different areas, situations and age 
groups. Although it is unknown if any of these agents can affect the population 
dynamics of lions in Zimbabwe, every translocation of animals of this species and 
introduction into another population should be carefully considered in the light of 
these findings. It is recommended that the serological status of animals destined for 
translocation be assessed whenever possible. 
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7 Figures and Tables 
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FIG. 1. Maps of Africa and of Zimbabwe. The free-ranging lions inhabited areas next to Lake Kariba, Mola (n=1), 
Bumi Hills (n=11), Fothergill Is. (n=3), Tashinga (n=2), also Chiredzi, Malilangwe (n=11), Zambezi Valley, Mana 
Pools (n=11), and Hwange National Park, Main Camp (n=2), Sinamatella (n=1. Numbers in parenthesis indicate 
the numbers of samples collected in the respective areas. In addition, Etosha National Park in Namibia, Kruger 
National Park in South Africa and Serengeti National Park in Tanzania are indicated. 
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TABLE 1. Comparison of the seroprevalence of different infectious agents in free-ranging and captive 
lions. 
Infectious Agent Free-ranging  Captive  Statisticsg 
 N pos./N prev. (95%-CI)  N pos./N prev. (95%-CI)  chi2 Ph 
FHVa 35/43 81% (67-92)  7/29 24% (10-44)  23.3 <0.01 
FCVa 0/43 0% (0-8)  1/29 3% (0-18)  i  
FPVa 10/43 23% (12-39)  11/29 38% (21-58)  1.8 n.s. 
FCoVa 3/43 7% (1-19)  3/29 10% (2-27)  i  
E. canisb 0/43 0% (0-8)  0/29 0% (0-12)  i  
A. phagocytophilumb 6/43 14% (5-28)  0/29 0% (0-12)  i  
CDVc  3/43 7% (1-19)  0/29 0% (0-12)  i  
FeLV (gp70)d 0/43 0% (0-8)  0/29 0% (0-12)  i  
T. gondiie 37/43 86% (72-95)  9/29 31% (15-51)  22.7 <0.01 
FIVf 22/42 52% (36-68)  6/29 21% (8-40)  7.2 <0.05 
a IFA titer ≥ 20. 
b IFA titer ≥ 80. 
c IFA titer ≥ 80 and confirmed using immunohistochemistry. 
d ELISA OD > 15% of pos. control and Western blot positive. 
e ELISA OD > 50% of pos. control. 
f Western blot: positive and questionable results were taken together and considered positive for the purpose of 
this table. 
g Actus randomization test 
h Bonferroni corrected P-values 
i less than 10 positive animals => no statistical analyses 
 
 
TABLE 2. Comparison of the seroprevalence of FHV, FPV, FCoV, FIV, A. phagocytophilum, T. gondii 
and CDV in free-ranging lions from different parts of Zimbabwe. 
No. of sera positive/no. tested for: 
Area 
FHVa  FPVa  FCoVa  FIVb  A. phag.c  T. gondiid  CDVe 
Zambezi Valley 
Mana Pools  9/11 (82%) 
 5/11 (45%)  2/11 (18%)  8/11 (73%)  2/11 (18%)  8/11 (73%)  0/11 (0%) 
Chiredzi 
Malilangwe 9/11 (82%) 
 3/11 (27%)  1/11 (9%)  7/11 (64%)  1/11 (9%)  10/11 (91%)  0/11 (0%) 
Lake Kariba 
Bumi Hills 8/11 (73%) 
 1/11 (9%)  0/11 (0%)  4/10 (40%)  2/11 (18%)  10/11 (91%)  0/11 (0%) 
Lake Kariba 
Mola 1/1  
 0/1   0/1   1/1   0/1   1/1   0/1  
Matusadona 
Fothergill Is. 3/3  
 1/3   0/3   2/3   1/3   3/3   2/3  
Matusadona 
Tashinga 2/2  
 0/2   0/2   0/2   0/2   2/2   1/2  
Hwange 
National Park 2/3   0/3   0/3   0/3   0/3   2/3   0/3  
a IFA titer ≥ 20.  
b Western blot: positive and questionable results were taken together and considered positive for the purpose of 
this table (more data will be presented separately). 
c A. phagocytophilum. 
d ELISA OD > 50% of pos. control. 
e IFA titer ≥ 80 and confirmed by immunohistochemistry. 
 
 
TABLE 3. Comparison of the results of the FIV-Western blot in free-ranging and captive lions in 
Zimbabwe. 
 FIVa 
 p24/p15 p24 Negative 
Free-ranging 4/42 (10%) 18/42 (43%) 20/42 (48%) 
Captive  2/29 (7%) 4/29 (14%) 23/29 (79%) 
a Western blot (n = 80, 1 sample not sufficient amount of serum). 
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TABLE 4. Relationship between antibodies to FIV and antibodies to FHV and T. gondii. 
Total (n=71)  Free-ranging (n=43)  Captive (n=29) 
No. of  sera positive or 
negative for antibody to:  
No. of  sera positive or 
negative for antibody to:  
No. of  sera positive or 
negative for antibody to: 
FHV  T. gondii  FHV  T. gondii  FHV  T. gondii 
FIV 
antibody 
status 
Pos. Neg.  Pos. Neg.  Pos. Neg.  Pos. Neg.  Pos. Neg.  Pos. Neg. 
Pos. 22 6  22 6  20 2  21 1  2 4  1 5 
Neg. 20 23  23 20  15 5  15 5  5 18  8 15 
                  
 pchi = 0.007  pchi = 0.032  NS  NS  NS  NS 
 
 
TABLE 5. Relationship between antibodies to T. gondii and antibodies to FHV, FPV and FCV (n = 81). 
Total (n=72)  Free-ranging (n=43)  Captive (n=29) 
No. of  sera positive or 
negative for antibody to:  
No. of  sera positive or 
negative for antibody to:  
No. of  sera positive or 
negative for antibody to: 
FHV  FPV  FHV  FPV  FHV  FPV 
T. gondii  
antibody 
status 
Pos. Neg.  Pos. Neg.  Pos. Neg.  Pos. Neg.  Pos. Neg.  Pos. Neg. 
Pos. 39 7  9 37  34 3  7 30  5 4  2 7 
Neg. 3 23  12 14  1 5  3 3  2 18  9 11 
                  
 pchi < 0 .001  pchi < 0 .001  PFisher < 0.001  NS  PFisher = 0.016  NS 
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